Biomarker research and some deduction in superficial bladder cancer cells combined with corresponding stroma

Cancer Biomarkers

Volumn 10, Issue 2, 2011, Pages 109-116

  Niu, Hai Tao ^a   Yang, Chuan Min ^a   Chen, Bo ^b   Dong, Qian ^a  

^a QINGDAO UNIVERSITY   (China)

^b China Petrochemical Corporation   (China)

Author keywords

biomarker; pathway; stroma; Superficial bladder cancer

Indexed keywords

PROTEOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CARCINOGENESIS; CARCINOMA CELL; CASE REPORT; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STROMA CELL; SUPERFICIAL BLADDER TRANSITIONAL CELL CARCINOMA; TANDEM MASS SPECTROMETRY; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MIDDLE AGED; PROTEOMICS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84859350667     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0235     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin 2010; 60: 244-272.
3. Bruyere F, Namdarian B, Corcoran NM, et al. Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers. Urol Oncol 2010; 28: 591-596.
4. Hegele A,Mecklenburg V, Varga Z, et al. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings. Anticancer Res 2010; 30: 5195-5200.
5. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009; 374: 239-249.
6. Hiscox S, Barrett-Lee P, Nicholson RI. Therapeutic targeting of tumor-stroma interactions. Expert Opin Ther Targets 2011; 15: 609-621.
7. Roth LM, Czernobilsky B. Perspectives on pure ovarian stromal neoplasms and tumor-like proliferations of the ovarian stroma. Am J Surg Pathol 2011; 35: e15-33.
8. Zhang GL, DeLuca DS, Brusic V. Database resources for proteomics-based analysis of cancer. Methods Mol Biol 2011; 723: 349-364.
9. Tong W, Harris S, Cao X, et al. Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 2004; 549: 241-253. (Pubitemid 38553987)
10. Yamazaki K, TakamuraM,Masugi Y, et al. Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest 2009; 89: 425-432.
11. Shao C, Liu Y, Ruan H, et al. Shotgun proteomics analysis of hibernating arctic ground squirrels. Mol Cell Proteomics 2010; 9: 313-326.
12. Stierum R, Gaspari M, Dommels Y, et al. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta 2003; 21: 73-91. (Pubitemid 38234572)
13. Kashani-Sabet M, Rangel J, Torabian S, et al. A multi-marker assay to distinguish malignant melanomas from benign nevi Proc. Natl Acad Sci U S A 2009; 106: 6268-6272.
14. Arends J. Metabolismin cancer patients.AnticancerRes 2010; 30: 1863-1868.
15. Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010; 9: 447-464.
16. Simons AL, Ahmad IM, Mattson DM, et al. 2-Deoxy-Dglucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 2007; 67: 3364-3370. (Pubitemid 46724876)
17. Fantin VR, St-Pierre J, Leder P.Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006; 9: 425-434. (Pubitemid 43832190)
18. Kotake Y, Sagane K, Owa T, et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol 2007; 3: 570-575. (Pubitemid 47294394)
19. Scita G, Di Fiore PP. The endocytic matrix. Nature 2010; 463: 464-473.
20. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin 2010; 60: 244-272.
21. Chung W, Bondaruk J, Jelinek J, et al. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev 2011; 20: 1483-1491.
22. Josson S, Matsuoka Y, Chung LW, et al. Tumor-stroma coevolution in prostate cancer progression and metastasis.Semin Cell Dev Biol 2010; 21: 26-32.
23. de Graauw M, van Miltenburg MH, Schmidt MK, et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 2010; 107: 6340-6345.
24. Thorn CC, Freeman TC, Scott N, et al. Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype. Gut 2009; 58: 404-412.
25. Scales CD Jr, Peterson B, Dahm P. Interpreting statistics in the urological literature. J Urol 2006; 176: 1938-1945. (Pubitemid 44633183)